http://www.xconomy.com/national/2009/04/16/amgen-shows-off-cancer-drug-pipeline-before-scientific-meeting/ Business + Technology in the Exponential Economy Sun, 22 Nov 2009 19:43:29 -0600 http://wordpress.org/?v=2.8.6 hourly 1 http://www.xconomy.com/national/2009/04/16/amgen-shows-off-cancer-drug-pipeline-before-scientific-meeting/comment-page-1/#comment-86450 Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent at Kerentech Sat, 10 Oct 2009 08:28:25 +0000 http://www.xconomy.com/?p=20536#comment-86450 [...] 2002 from Seattle-based Immunex, but has more recently sought to re-ignite its innovation engine, particularly for cancer drugs, this decade under R&D boss Roger Perlmutter, a former Merck executive and University of [...] [...] 2002 from Seattle-based Immunex, but has more recently sought to re-ignite its innovation engine, particularly for cancer drugs, this decade under R&D boss Roger Perlmutter, a former Merck executive and University of [...]

]]> http://www.xconomy.com/national/2009/04/16/amgen-shows-off-cancer-drug-pipeline-before-scientific-meeting/comment-page-1/#comment-57439 Alan F. Hall Tue, 12 May 2009 06:39:44 +0000 http://www.xconomy.com/?p=20536#comment-57439 Is any one familiar with the work of Immunovaative Technologies Ltd.? Is any one familiar with the work of Immunovaative Technologies Ltd.?

]]> http://www.xconomy.com/national/2009/04/16/amgen-shows-off-cancer-drug-pipeline-before-scientific-meeting/comment-page-1/#comment-53880 Heath News: China environmentally friendly health care wet towel … | Tested on Humans Fri, 17 Apr 2009 17:33:05 +0000 http://www.xconomy.com/?p=20536#comment-53880 [...] and Amgen Shows Off Cancer Drug Pipeline Before Scientific Meeting  … for cancer drugs doubled in recent years, and is projected to reach $67 billion worldwide in 2012, according to market research firm Decision Resources. … See all stories on this topic, more  [...] [...] and Amgen Shows Off Cancer Drug Pipeline Before Scientific Meeting  … for cancer drugs doubled in recent years, and is projected to reach $67 billion worldwide in 2012, according to market research firm Decision Resources. … See all stories on this topic, more  [...]

]]> http://www.xconomy.com/national/2009/04/16/amgen-shows-off-cancer-drug-pipeline-before-scientific-meeting/comment-page-1/#comment-53836 News, Money and Drugs for April 16, 2009 | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes Sneaky Fri, 17 Apr 2009 00:48:40 +0000 http://www.xconomy.com/?p=20536#comment-53836 [...] Finally, Amgen wants everyone to look at their preclinical pipeline for AACR. Interesting yes, but c’mon: we want NDA filings/Phase 3 data/approvals/complete responses!!! Zzzzzzzzzzzzz. Wake us up when the conference is over (when’s ASCO btw?) [Xconomy] [...] [...] Finally, Amgen wants everyone to look at their preclinical pipeline for AACR. Interesting yes, but c’mon: we want NDA filings/Phase 3 data/approvals/complete responses!!! Zzzzzzzzzzzzz. Wake us up when the conference is over (when’s ASCO btw?) [Xconomy] [...]

]]>